|
시장보고서
상품코드
2055118
인공 장기 시장 : 장기 유형별Artificial Organ Market, By Organ Type (Artificial Heart, Artificial Kidney, Artificial Liver, By Patient Type, By End User, By Application, By Technology, By Geography ) |
||||||
인공 장기 시장은 2026년에 234억 달러로 추정되며, 2033년까지 422억 3,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 8.8%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 234억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 8.80% | 2033년 시장 규모 예측 : | 422억 3,000만 달러 |
세계 인공 장기 시장은 의료 기술 분야의 혁신적인 개척 분야로서, 전 세계적인 기증 장기 부족 문제에 대처하는 동시에 장기 부전으로 고통받는 수백만 명의 환자에게 희망을 주고 있습니다. 기능 부전에 빠진 생체 장기의 기능을 대체하거나 보조하도록 설계된 인공 장기는 기계 장치, 생체공학 조직, 하이브리드 시스템 등 다양한 기술을 포함하고 있습니다.
이 시장은 인공 심장, 신장, 폐, 간, 췌장, 사지 등 다양한 장기 유형에 걸쳐 있으며, 각각이 첨단 재료 과학, 생체 적합성 공학 및 선진 제조 기술을 활용하고 있습니다. 만성 질환 유병률 증가, 고령화, 생활습관병으로 인한 장기 부전 증가로 인해 인공 장기 솔루션에 대한 수요가 높아지고 있습니다. 이러한 생명을 구하는 기술은 이식을 기다리는 환자의 생명을 유지하는 일시적인 가교 장치부터 정상적인 생리 기능을 회복시키는 영구적인 장기 이식에 이르기까지 다양합니다.
이 시장은 생체 재료, 3D 프린팅, 조직 공학, 재생 의학 분야의 최첨단 혁신 기술을 활용하여 이식형 기기와 체외 지원 시스템 모두를 아우르고 있습니다. 전 세계 의료 시스템이 장기 기증자 부족과 대기 기간의 장기화에 직면한 가운데, 인공 장기는 즉각적인 이용 가능성, 사양 맞춤화, 그리고 기존 장기 이식에 수반되는 면역학적 거부 반응의 위험을 제거해 준다는 점에서 유망한 대안으로 부상하고 있습니다.
시장 역학
세계 인공 장기 시장은 현대 의료에서 그 지극히 중요한 역할을 입증하는 몇 가지 강력한 촉진요인에 의해 주도되고 있습니다. 주된 원인은 전 세계적으로 기증 장기가 심각하게 부족하기 때문입니다. 현재 미국에서는 10만 명 이상이 장기 이식 대기자 명단에 등록되어 있으며, 전 세계적으로도 유사한 통계가 나타나고 있어 인공 장기를 통한 대체 수단에 대한 시급한 필요성이 대두되고 있습니다. 당뇨병, 심혈관 질환, 신부전, 간경변 등 만성 질환의 유병률 증가와 더불어 고령화가 진행됨에 따라, 장기 이식 솔루션에 대한 수요가 크게 증가하고 있습니다.
생체 재료, 3D 바이오 프린팅, 조직 공학, 나노기술 분야의 기술적 진보는 인공 장기 개발에 혁명을 일으키고 있으며, 장치의 생체 적합성, 내구성, 기능성을 향상시키고 있습니다. 연구 개발을 지원하는 정부의 이니셔티브, 의료비 증가, 그리고 인공 장기의 장점에 대한 인식 제고가 시장 성장을 더욱 가속화하고 있습니다. 그러나 시장은 매우 높은 개발 및 제조 비용을 포함한 큰 제약에 직면해 있어, 인공 장기는 가격이 비싸 많은 환자들이 이용하기 어려울 수 있습니다. 광범위한 임상시험과 안전성 검증이 필요한 엄격한 규제 승인 절차는 제조업체에게 장기간의 개발 기간과 막대한 재정적 부담을 안겨주고 있습니다. 생체 적합성, 기기의 내구성, 감염 위험, 그리고 천연 장기와 동등한 기능성 구현과 관련된 기술적 과제는 여전히 큰 걸림돌로 남아 있습니다. 보험사의 보상 범위 제한과 인공 장기 도입에 대한 윤리적 우려 또한 시장 확대를 제약하고 있습니다.
이러한 과제가 있음에도 불구하고, 의료 인프라 개선, 의료 관광 증가, 가처분 소득 상승이 나타나고 있는 신흥 시장에는 막대한 기회가 존재합니다. 학술 기관, 생명공학 기업, 의료기기 제조업체 간의 공동 연구는 혁신을 촉진하고 제품 개발을 가속화하고 있습니다. 인공 장기 설계에 인공지능, 머신러닝, IoT 기술을 통합하면 기능을 실시간으로 모니터링하고 조정할 수 있는 스마트하고 적응성이 뛰어난 기기를 개발할 수 있는 혁신적인 기회를 제공하며, 이는 환자의 예후와 시장 역학을 변화시킬 잠재력을 지니고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 파라미터(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)를 바탕으로 전 세계 인공 장기 시장의 주요 기업 프로파일을 작성했습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계 인공 장기 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 세계 인공 장기 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 인공 장기 시장 : 장기 유형별, 2021년-2033년
제5장 세계의 인공 장기 시장 : 환자 유형별, 2021년-2033년
제6장 세계의 인공 장기 시장 : 최종사용자별, 2021년-2033년
제7장 세계의 인공 장기 시장 : 용도별, 2021년-2033년
제8장 세계의 인공 장기 시장 : 기술별, 2021년-2033년
제9장 세계의 인공 장기 시장 : 지역별, 2021년-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
LSH 26.06.22Artificial Organ Market is estimated to be valued at USD 23.40 Bn in 2026 and is expected to reach USD 42.23 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 23.40 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.80% | 2033 Value Projection: | USD 42.23 Bn |
The global artificial organ market represents a revolutionary frontier in medical technology, addressing the critical shortage of donor organs worldwide while offering hope to millions of patients suffering from organ failure. Artificial organs, engineered medical devices designed to replace or support the function of failing biological organs, encompass a diverse range of technologies including mechanical devices, bioengineered tissues, and hybrid systems.
This market spans various organ types such as artificial hearts, kidneys, lungs, liver, pancreas, and limbs, each utilizing sophisticated materials science, biocompatibility engineering, and advanced manufacturing techniques. The increasing prevalence of chronic diseases, aging populations, and lifestyle-related organ failures has intensified the demand for artificial organ solutions. These life-saving technologies range from temporary bridging devices that sustain patients awaiting transplants to permanent organ replacements that restore normal physiological function.
The market encompasses both implantable devices and external support systems, leveraging cutting-edge innovations in biomaterials, 3D printing, tissue engineering, and regenerative medicine. As healthcare systems worldwide grapple with organ donor shortages and extended waiting lists, artificial organs emerge as a promising alternative, offering immediate availability, customizable specifications, and elimination of immunological rejection risks associated with traditional organ transplantation.
Market Dynamics
The global artificial organ market is propelled by several compelling drivers that underscore its critical importance in modern healthcare. The primary driver stems from the severe shortage of donor organs worldwide, with over 100,000 Americans currently on organ waiting lists and similar statistics globally, creating an urgent need for artificial alternatives. Rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, kidney failure, and liver cirrhosis, coupled with aging populations, significantly amplifies demand for organ replacement solutions.
Technological advancements in biomaterials, 3D bioprinting, tissue engineering, and nanotechnology are revolutionizing artificial organ development, making devices more biocompatible, durable, and functionally superior. Government initiatives supporting research and development, increased healthcare expenditure, and growing awareness about artificial organ benefits further accelerate market growth. However, the market faces substantial restraints including extremely high development and manufacturing costs, making artificial organs expensive and potentially inaccessible to many patients. Stringent regulatory approval processes requiring extensive clinical trials and safety validations create lengthy timelines and significant financial barriers for manufacturers. Technical challenges related to biocompatibility, device longevity, infection risks, and achieving natural organ functionality remain significant hurdles. Limited reimbursement coverage by insurance providers and ethical concerns regarding artificial organ implementation also constrain market expansion.
Despite these challenges, immense opportunities exist through emerging markets with improving healthcare infrastructure, increasing medical tourism, and rising disposable incomes. Collaborative research between academic institutions, biotechnology companies, and medical device manufacturers is fostering innovation and accelerating product development. The integration of artificial intelligence, machine learning, and IoT technologies in artificial organ design presents revolutionary opportunities for smart, adaptive devices that can monitor and adjust their functionality in real-time, potentially transforming patient outcomes and market dynamics.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global artificial organ market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include leading Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Asahi Kasei Corporation, Fresenius Medical Care AG, Baxter International Inc., SynCardia Systems LLC, Jarvik Heart Inc., Cochlear Limited, Ottobock SE & Co. KGaA, Second Sight Medical Products, Ekso Bionics Holdings Inc., Abiomed Inc., Organovo Holdings Inc., and Carmat SA.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global artificial organ market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial organ market.
Market Segmentation
- Organ Type Insights (Revenue, USD Bn, 2021 - 2033)
- Artificial Heart
- Ventricular Assist Devices (VADs)
- Total Artificial Hearts (TAHs)
- Artificial Kidney
- Wearable Artificial Kidneys
- Implantable Renal Devices
- Artificial Liver
- Bioartificial Liver Support Systems
- Extracorporeal Liver Assist Devices
- Artificial Pancreas
- Closed-Loop Insulin Delivery Systems
- Implantable Glucose Monitors
- Artificial Lungs
- Extracorporeal Membrane Oxygenation (ECMO)
- Implantable Oxygenators
- Sensory Organs
- Cochlear Implants (Hearing)
- Retinal Implants (Vision)
- Corneal Implants
- Bionic Limbs
- Myoelectric Prosthetics
- Others (Neuro-Controlled Prostheses)
- Patient Type Insights (Revenue, USD Bn, 2021 - 2033)
- Neonates
- Pediatric
- Adult
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Transplant Centers
- Ambulatory Surgical Centers
- Emergency and Trauma Centers
- Home Care Settings
- Others (Research Institutes, etc.)
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Transplantation
- Chronic Disease Management
- Other Emergency or Acute Care
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Mechanical
- Electronic or Bionic
- Biomechanical Hybrid
- Biomaterials-Based Technology (e.g., Decellularized Scaffolds, 3D-Bioprinted Tissues)
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- Asahi Kasei Corporation
- Fresenius Medical Care AG
- Baxter International Inc.
- SynCardia Systems LLC
- Jarvik Heart Inc.
- Cochlear Limited
- Ottobock SE & Co. KGaA
- Second Sight Medical Products
- Ekso Bionics Holdings Inc.
- Abiomed Inc.
- Organovo Holdings Inc.
- Carmat SA
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Artificial Organ Market, By Organ Type
- Global Artificial Organ Market, By Patient Type
- Global Artificial Organ Market, By End User
- Global Artificial Organ Market, By Application
- Global Artificial Organ Market, By Technology
- Global Artificial Organ Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Artificial Organ Market, By Organ Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Artificial Heart
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ventricular Assist Devices (VADs)
- Total Artificial Hearts (TAHs)
- Artificial Kidney
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Wearable Artificial Kidneys
- Implantable Renal Devices
- Artificial Liver
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Bioartificial Liver Support Systems
- Extracorporeal Liver Assist Devices
- Artificial Pancreas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Closed-Loop Insulin Delivery Systems
- Implantable Glucose Monitors
- Artificial Lungs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Extracorporeal Membrane Oxygenation (ECMO)
- Implantable Oxygenators
- Sensory Organs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cochlear Implants (Hearing)
- Retinal Implants (Vision)
- Corneal Implants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Bionic Limbs
- Myoelectric Prosthetics
- Others (Neuro-Controlled Prostheses)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Artificial Organ Market, By Patient Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Neonates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Artificial Organ Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Transplant Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Emergency and Trauma Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Artificial Organ Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Transplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chronic Disease Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Emergency or Acute Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Artificial Organ Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Mechanical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Electronic or Bionic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biomechanical Hybrid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biomaterials-Based Technology (e.g., Decellularized Scaffolds, 3D-Bioprinted Tissues)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Artificial Organ Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Asahi Kasei Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fresenius Medical Care AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SynCardia Systems LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jarvik Heart Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cochlear Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ottobock SE & Co. KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Second Sight Medical Products
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ekso Bionics Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abiomed Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Organovo Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Carmat SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
